Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
about
New Perspectives on Diagnosis and Therapy of Malignant Pleural Mesothelioma.Targeting the Hippo Pathway Is a New Potential Therapeutic Modality for Malignant Mesothelioma.Soluble CD157 in pleural effusions: a complementary tool for the diagnosis of malignant mesothelioma.Thrombin Assessment on Nanostructured Label-Free Aptamer-Based Sensors: A Mapping Investigation via Surface-Enhanced Raman Spectroscopy.Breath analysis as a diagnostic and screening tool for malignant pleural mesothelioma: a systematic review
P2860
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
@en
type
label
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
@en
prefLabel
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
@en
P2093
P2860
P356
P1433
P1476
Biomarkers for early diagnosis of malignant mesothelioma: Do we need another moonshot?
@en
P2093
Jan P van Meerbeeck
Karim Y Vermaelen
Sabrina Lagniau
P2860
P304
53751-53762
P356
10.18632/ONCOTARGET.17910
P407
P50
P577
2017-05-17T00:00:00Z